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Background: Perioperative goal-directed fluid therapy (GDFT) may improve outcome after high-risk surgery. Minimal
invasive measurement of stroke volume variation (SVV) has been recommended to guide fluid therapy. We intended to
study how perioperative GDFT with arterial-based continuous SVV monitoring influences postoperative complications
in a high-risk surgical population.
Methods: From February 1st 2012, all ASA 3 and 4 patients undergoing abdominal surgery in two university hospitals
were assessed for randomization into a control group or GDFT group. An arterial-line cardiac output monitor was used
to measure SVV, and fluid was given after an algorithm in the intervention group. Restrictions of the method excluded
patients undergoing laparoscopic surgery, patients with atrial fibrillation and patients with severe mitral/aortal stenosis.
To detect a decrease in number of complication from 40 % in the control group to 20 % in the GDFT group, n = 164
patients were needed (power 80 %, alpha 0.05, two-sided test). To include the needed amount of patients, the study
was estimated to last for 2 years.
Results: After 1 year, 30 patients were included and the study was halted due to slow inclusion rate. Of 732 high-risk
patients scheduled for abdominal surgery, 391 were screened for randomization. Of those, n = 249 (64 %) were
excluded because a laparoscopic technique was preferred and n = 95 (24 %) due to atrial fibrillation.
Conclusions: Our study was stopped due to a slow inclusion rate. Methodological restrictions of the arterial-line
cardiac output monitor excluded the majority of patients. This leaves the question if this method is appropriate
to guide fluid therapy in high-risk surgical patients.
Trial registration: ClinicalTrials.gov: NCT01473446.Background
Maintaining adequate oxygen supply to body organs is
one of the main goals during anaesthesia, and giving
intravenous fluid is one way to achieve this goal. A
Cochrane systematic review found that complication rate
and length of hospital stay, but not mortality, were re-
duced when global blood flow is optimized periopera-
tively by means of fluid and or drugs [1].* Correspondence: ib.jammer@helse-bergen.no
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creativecommons.org/publicdomain/zero/1.0/Recent studies show the development and use of sev-
eral minimal invasive methods to estimate cardiac out-
put and guide fluid therapy [2]. Despite the unclear
evidence in the literature and contradictory findings in
clinical trials, the pressure on clinicians to use a goal-
directed fluid therapy approach is high. In the UK, there
is even a governmental financial incentive for hospitals
to use Oesophageal Doppler for its patients [3] because
the goal-directed approach may be cost effective [4].
High-risk patient may have the greatest benefit of a
goal-directed fluid approach [5, 6]. Less capability to
compensate hypo- and hypervolemia may increase thearticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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ance [7, 8]. Benes et al. evaluate the effect of minimal
invasive cardiac output-monitored fluid therapy exclu-
sively in a high-risk abdominal surgery population [9].
Pearse describes the use of an arterial-line cardiac out-
put monitoring in a high-risk surgery population [10].
Both studies where done on high-risk patients, using a
strict definition of “high-risk”. However, we could not
find a consensus in the literature about the definition
of “high-risk surgery”. To simplify our approach to
high-risk surgery, we defined therefore ASA 3 and 4
patients as high-risk patients. Then we intended to
conduct a multicentre international prospective clinical
trial to study what impact goal-directed fluid therapy
based on continuous SVV (stroke volume variation) moni-
toring has on postoperative complications in this patient
group.
Methods
Trial design
We planned a two-centre, assessor concealed, prospect-
ive randomized clinical trial conducted in Norway and
Finland. The trial was approved by the institutional
board in Norway (2011/947/REK Vest) and Finland
(EETTMK:10/2012).
Participants
From 1 February 2012 to 31 January 2013, all high-risk
patients defined by ASA score 3 and 4, older than
18 years scheduled for major abdominal surgery in two
university hospitals were assessed for eligibility. Patients
who were able to give consent when an investigator was
available were screened for eligibility. Patient undergoing
liver or oesophageal surgery where not screened because
they follow a more restrictive fluid regimen. Exclusion
criteria after screening were the following: atrial fibrilla-
tion, severe aortic or mitral stenosis, and laparoscopic
surgery or declined participation. Patients were included
consecutively. Informed consent was obtained from each
randomized patient.
Interventions
Patients were randomized into two groups: a control
group receiving traditional fluid therapy and a group
with a goal-directed fluid therapy (GDFT) regimen
guided by an arterial pressure-based cardiac output de-
vice (LiDCOrapid, LiDCO Ltd, London, UK) to measure
SVV [11]. For more details of the study protocol, see
Additional file 1.
Sample size calculation
The complication rate for lower gastrointestinal surgery
in elective patients in one of the study hospitals was
40 % in a previous study [12]. In the present study, ahigher complication rate was expected due to inclusion
of a population with a higher morbidity. To detect a de-
crease in number of complication from 40 % in the con-
trol group to 20 % in the GDFT group, n = 164 patients
were needed (power 80 %, alpha 0.05, two-sided test). It
was estimated that with an approximate inclusion rate of
80 patients/year in each study centre, the study could be
conducted within 2 years.
Interim analysis
Due to an unexpectedly low inclusion rate, an analysis of
the exclusion factors was performed after 1 year. This
resulted in termination of the study. A retrospective ana-
lysis of all patients undergoing abdominal surgery within
the last year and their comorbidities and surgical tech-
niques was undertaken after approval of the institutional
board.
Outcomes
The primary endpoint was the proportion of patients
suffering of one or more complication within 5 days
postoperatively.
After termination of the study, we decided to reject
the primary outcome due to heavy underpowered sam-
ple size. To analyse reasons for exclusion, we determined
the amount of excluded patients. No statistical analysis
was performed of the numbers collected.
Results
Participant flow
During 1 year, n = 732 high-risk patients were scheduled
for abdominal surgery.
Of these, n = 341 were not screened for inclusion. Rea-
sons were either no investigator present or equipment
missing (n = 224), scheduled liver or oesophagus surgery
(n = 64) or the patient were unable to give informed con-
sent (n = 53).
Of all scheduled patients, n = 391 patients were
screened for randomisation. Of these, 64 % (n = 249)
were excluded because a laparoscopic technique was
preferred, and 24 % (n = 95) were excluded due to atrial
fibrillation. The patient flow through the study can be
seen in Fig. 1. Of all screened patients, only 7.7 % (n = 30)
could be included in the study. The outcome data is
presented by study group allocation in Table 1. A
de-identified database containing all collected data of
included patients is available online as an additional file
(see Additional file 2).
Reason for stopped trial
After 1 year, the number of randomized patients we
could include in the study was only 18 % of the esti-
mated number we have been expected at that time. We
Fig. 1 Flow diagram for patients’ progression through the trial
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last more than 5 years and therefore decided to termin-
ate the study early.
Discussion
Principal findings
In our study, a majority of high-risk surgical patients de-
fined as ASA 3 and ASA 4 were not eligible for an
arterial-line-based GDFT approach. The main reasons
are methodological limitations of the arterial-line wave-
form analysis. The majority of patients had to be ex-
cluded because a laparoscopic surgical technique was
preferred or due to atrial fibrillation.
This study was meant to be a prospective randomized
controlled trial with a pragmatic approach to include pa-
tients. This would reflect daily routines, strengthening
the study. Because the study was conducted in two ter-
tiary hospitals, we had a high amount of high-risk surgi-
cal patients. Therefore, we expected to include enough
patients in short time to run a well-powered study. Of
732 patients, 224 were not screened for randomisation
due to investigator or equipment not being available. If
this patient group also could have been screened, we
may have had a higher number of patients randomized.
However, it is to assume that the same fraction of pa-
tients would have to be excluded due to laparoscopic
surgery and atrial fibrillation. Therefore, we do not be-
lieve that the total amount of patients that could be ran-
domized would be much higher.
We terminated the study early, resulting in a heavily
underpowered study. The primary outcome, postopera-
tive morbidity, cannot be assessed since we just included30 patients, and a statistical analysis would be meaning-
less. Consequently, we present just the patient flow
numbers and not a complete statistical analysis of
complications.
The low number of patients that could possibly
benefit from GDFT is valid for our hospitals where the
surgeons prefer to operate on high-risk patients with
minimal invasive surgery. In hospitals that perform a
higher amount of open surgery, the use of a minimal
invasive GDFT approach may be more feasible.
We define the high-risk surgical patient by the ASA
score to make the study pragmatic. However, other au-
thors define “high-risk surgery” or the “high-risk patient”
in different ways [13–15]. This makes comparison of tri-
als dealing with this patient group difficult.
Maguire found in a retrospective electronic chart
study of his hospital that n = 12.308 patients underwent
surgery in 1 year, but only n = 4.792 (39 %) fulfilled the
criteria for an arterial-line-based cardiac output monitor,
and of these, only 23.2 % had an arterial-line. There was
no report on how many of the patients were ASA III/IV
patients [16].
Arterial-line-based waveform analysis measures
hemodynamics by calculation of stroke volume vari-
ation or pulse pressure variation. However, arterial-
line-based output methods are not applicable to large
patient groups due to their limitations [16]. One limitation
is laparoscopic procedures [17]. The increased intraabdom-
inal pressure from the pneumoperitoneum affects dynamic
parameters independently in changes of volume status
[17–19]. Consequently would SVV during pneumoperito-
neum increase while the blood volume do not decrease, it
Table 1 Complications (definition) within 5 days after surgery
Intervention
group
Control
group
n = 14 n = 16
Pulmonary
Pneumonia (x-ray + antibiotics) 4 0
Pleural fluid (supplemental oxygen + x-ray) 0 2
Atelectasis (supplemental oxygen + x-ray) 3 1
Pneumothorax 0 0
Respiratory failure (intensive care
treatment)
2 1
Pulmonary emboli (computed tomography
+ treatment)
0 0
Cardial
Arrytmia (electrocardiogram + treatment
or cardiologist consultation)
2 1
Coronary ischemia (electrocardiogram +
troponin)
0 0
Pulmonary stasis/oedema (x-ray or
treatment)
1 1
Neurological
Postoperative delirium (treatment) 1 2
Focal neurological deficit 0 0
Infectious
Wound infection (phlegmone + antibiotics
or drainage)
0 0
Intraabdominal infection (computed
tomography + antibiotics)
0 0
Central venous catheter infection 0 0
Wound rupture (operation) 0 0
Gastrointestinal (GI)
Mechanical ileus (operation) 0 1
GI bleeding (transfusion or gastroscopy) 0 0
Paralytic ileus (unable to tolerate enteral
diet > 5 days)
1 2
Others
Renal impairment (creatinine increase >
33 %)
0 1
Impaired spontaneous voiding
(catheterization > 2 times)
1 0
Venous thrombosis (treatment) 0 0
Sum of complications 15 12
Patients with at least one complication 7 7
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not well validated in humans [21, 22]. Other limitations of
waveform analysis measurements are cardiac arrhythmias
and patients with severe cardiac valvulopatias [23].
Despite criticism about the evidence of the effect of
goal-directed therapy, one single method of minimal in-
vasive cardiac output monitoring (Oesophagus Doppler)has even been officially recommended in the National
Institute for Health and Clinical Excellence guidelines
of the UK (http://www.nice.org.uk/guidance/MTG3).
This decision has been criticized due to the lack of
proof [24, 25], and the method may not be superior to
a strategy of a neutral balance [26]. Other studies have
not found benefices in a goal-directed fluid approach
[10, 12, 26–30], have not found benefit using a restrict-
ive fluid approach [31] or even have worse outcome in
physically fit patients [5].
It is biologically plausible that the right amount of fluid
given at the right time increase oxygen delivery to the or-
gans and thereby benefit patient outcome. There has been
a meta-analysis confirming that a GDFT approach may
decrease postoperative complications. However, many
included studies are small single centre studies with a high
risk of bias or methodological limitations [1, 32, 6]. The
effect on outcome in these studies is mostly small. An
even statistical distribution of different studies with a
small effect size would consequently result in a number of
studies that would show no effect or even harm. The
marked overweight of studies with a small positive effect
on outcome may indicate a publication bias favouring tri-
als with positive results. This may mask limitations of the
arterial-line-based GDFT method that we report. Other
studies investigating high-risk surgical patients do not
report the exclusion rate due to atrial fibrillation when this
condition restricted the GDFT method used [5, 9].
The OPTIMIZE trial with a study population of 734
patients is the largest trial on GDFT to date. It could
not show a reduction of complications after periopera-
tive arterial-line-based GDFT. However, when including
the OPTIMIZE trial in an updated Cochrane meta-
analysis, it indicates a reduced complication rate [10].
Goal-directed fluid therapy may be more important in a
high-risk surgery population than in a relatively healthy
population. Limitations of the method with an arterial-
line-based monitor may cause exclusion of a patient group
who may benefit most of the treatment. In the UK, it is
recommended to use an Oesophagus Doppler to guide
fluid therapy preoperatively. The same limitations that
apply to the arterial-line-based method (exclusion of
patient with atrial fibrillation and laparoscopic procedures)
would apply to this method too.
Conclusions
Our primary goal was to investigate if high-risk surgical
patients benefit from SVV-guided fluid therapy. This
question still remains open. A majority of our patients
had to be excluded from the trial due to methodo-
logical limitations. This leaves the question whether or
not an arterial-line-based cardiac output monitor is the
best method to guide fluid therapy in high-risk surgical
patients.
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